Moderna (MRNA) stock rose after confirming Nasdaq-100 inclusion, even as Citi downgrades the stock on valuation concerns.
Citi raises its Strategy price target to $240 from $136 as a higher Bitcoin forecast and expected mNAV expansion strengthen ...
Citigroup is upgraded based on strong operating results and a somewhat improved starting valuation. Click to read more on the ...
Rocket Lab stock is higher after its biggest-ever Electron launch deal and a new Citi Buy rating. Here is what is driving ...
AMC Entertainment Holdings Inc. stocks have been trading down by -9.17 percent amid bearish sentiment over weakening box office revenues. Key Takeaways AMC is pushing out major debt maturities by ...
AMC Entertainment Holdings Inc. stocks have been trading down by -9.17 percent amid sharply negative sentiment over weakening ...
Rocket Lab secures 20 additional launches for Synspective, while Citi initiates coverage with a Buy rating and $105 price ...
Moderna Climbs 3% Despite Citigroup’s Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water
Buyers are stepping into Moderna (NASDAQ:MRNA | MRNA Price Prediction) shares, evidently. The move comes one session after a ...
Citi, Barclays, and Wells Fargo all lifted their HPE price targets after Networking Investor Day, yet the three firms land in ...
SanDisk (SNDK) stock gained 1%+ after Micron's strong NAND results. Citi maintains Buy rating as tight memory pricing ...
SanDisk (SNDK) stock gained 1%+ after Micron's strong NAND results showed 42% revenue growth. Citi keeps Buy rating with ...
Rocket Lab (RKLB) stock rises after Citi initiates a Buy rating and the company lands its largest-ever Electron launch deal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results